Ikena Oncology, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
ImageneBio, Inc., formed from the merger of Ikena Oncology and Inmagene Biopharmaceuticals, filed an S-1 registration statement for the resale of 2,508,337 common shares by selling stockholders following a $75 million PIPE financing.